Attitudes and Practices Regarding Use of Progesterone to Prevent Preterm Births

 

 Buy Article Permissions and Reprints

ABSTRACT

We sought to describe current attitudes and practices of obstetrician-gynecologists regarding use of progesterone and prevention of preterm birth. A self-administered survey was mailed to American College of Obstetricians and Gynecologists Fellows and Junior Fellows in Practice in March to May 2007. The survey consisted of 36 questions, including respondents' demographic characteristics, preterm birth risk factor knowledge and screening practices, and use of progesterone for the prevention of preterm birth. The response rate was 52% (n = 345); most respondents were general obstetrician-gynecologists (89%). Many (74%) reported recommending or offering progesterone for prevention of preterm birth. Almost all (93%) reported use for the indication of previous spontaneous preterm birth. However, many also reported use for other indications such as dilated/effaced cervix (37%), short cervix on ultrasound (34%), and cerclage (26%). These results suggest that most obstetricians recommend or offer progesterone to prevent preterm birth for women with a previous spontaneous preterm birth and many also offer it for women with other high-risk obstetric conditions.

REFERENCES

• 1 Hamilton B E, Minino A M, Martin J A, Kochanek K D, Strobino D M, Guyer B. Annual summary of vital statistics: 2005.  Pediatrics. 2007;  119 345-360
  CrossrefPubMedGoogle Scholar
• 2 da Fonseca E B, Bittar R E, Carvalho M H, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study.  Am J Obstet Gynecol. 2003;  188 419-424
  CrossrefPubMedGoogle Scholar
• 3 Meis P J, Klebanoff M, Thom E et al.. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate.  N Engl J Med. 2003;  348 2379-2385
  CrossrefPubMedGoogle Scholar
• 4 American College of Obstetricians and Gynecologists . ACOG Committee Opinion. Use of progesterone to reduce preterm birth.  Obstet Gynecol. 2003;  102 1115-1116
  CrossrefPubMedGoogle Scholar
• 5 Norwitz E R, Bahtiyar M O, Sibai B M. Defining standards of care in maternal-fetal medicine.  Am J Obstet Gynecol. 2004;  191 1491-1496
  CrossrefPubMedGoogle Scholar
• 6 Ness A, Baxter J, Hyslop T, Berghella V. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States.  J Reprod Med. 2006;  51 411-415
  PubMedGoogle Scholar
• 7 Ness A, Dias T, Damus K, Burd I, Berghella V. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey.  Am J Obstet Gynecol. 2006;  195 1174-1179
  CrossrefPubMedGoogle Scholar
• 8 Coleman V H, Power M L, Zinberg S, Schulkin J. Contemporary clinical issues in outpatient obstetrics and gynecology: findings of the Collaborative Ambulatory Research Network, 2001–2004: part II.  Obstet Gynecol Surv. 2004;  59 787-794
  CrossrefPubMedGoogle Scholar
• 9 Coleman V H, Power M L, Zinberg S, Schulkin J. Contemporary clinical issues in outpatient obstetrics and gynecology: findings of the Collaborative Ambulatory Research Network, 2001–2004: part I.  Obstet Gynecol Surv. 2004;  59 780-786
  CrossrefPubMedGoogle Scholar
• 10 Fonseca E B, Celik E, Parra M, Singh M, Nicolaides K H. Progesterone and the risk of preterm birth among women with a short cervix.  N Engl J Med. 2007;  357 462-469
  CrossrefPubMedGoogle Scholar
• 11 Gulmezoglu A M, Langer A, Piaggio G, Lumbiganon P, Villar J, Grimshaw J. Cluster randomised trial of an active, multifaceted educational intervention based on the WHO Reproductive Health Library to improve obstetric practices.  BJOG. 2007;  114 16-23
  PubMedGoogle Scholar
• 12 Parer J T. Obstetric technologies: what determines clinical acceptance or rejection of results of randomized controlled trials?.  Am J Obstet Gynecol. 2003;  188 1622-1625
  CrossrefPubMedGoogle Scholar
• 13 Thorp J. Evidence-based medicine—where is your effectiveness?.  BJOG. 2007;  114 1-2
  PubMedGoogle Scholar
• 14 Kellerman S E, Herold J. Physician response to surveys. A review of the literature.  Am J Prev Med. 2001;  20 61-67
  PubMedGoogle Scholar
• 15 Power M L, Cogswell M E, Schulkin J. Obesity prevention and treatment practices of U.S. obstetrician-gynecologists.  Obstet Gynecol. 2006;  108 961-968
  CrossrefPubMedGoogle Scholar
• 16 Dodd J M, Ashwood P, Flenady V, Jenkins-Manning S, Cincotta R, Crowther C A. A survey of clinician and patient attitudes towards the use of progesterone for women at risk of preterm birth.  Aust N Z J Obstet Gynaecol. 2007;  47 106-109
  CrossrefPubMedGoogle Scholar
• 17 Northen A T, Norman G S, Anderson K et al.. Follow-up of children exposed in utero to 17 alpha-hydroxyprogesterone caproate compared with placebo.  Obstet Gynecol. 2007;  110 865-872
  CrossrefPubMedGoogle Scholar
• 18 Thornton J G. Progesterone and preterm labor–still no definite answers.  N Engl J Med. 2007;  357 499-501
  PubMedGoogle Scholar
• 19 O'Brien J M, Adair C D, Lewis D F et al.. Progesterone vaginal gel for the reduction of recurrent preterm birth: primary results from a randomized, double-blind, placebo-controlled trial.  Ultrasound Obstet Gynecol. 2007;  30 687-696
  CrossrefPubMedGoogle Scholar
• 20 Rouse D J, Caritis S N, Peaceman A M et al.. A trial of 17 alpha-hydroxyprogesterone caproate to prevent prematurity in twins.  N Engl J Med. 2007;  357 454-461
  CrossrefPubMedGoogle Scholar
• 21 Dodd J M, Flenady V J, Cincotta R et al.. Progesterone for the prevention of preterm birth: a systematic review.  Obstet Gynecol. 2008;  112 127-134
  CrossrefPubMedGoogle Scholar
• 22 Thornton J G. Supplement to: progesterone and preterm labor—still no definite answers.  N Engl J Med. 2007;  357 499-501
  PubMedGoogle Scholar
• 23 American College of Obstetricians and Gynecology . ACOG Committee Opinion number 419. Use of progesterone to reduce preterm birth.  Obstet Gynecol. 2008;  112 963-965
  CrossrefPubMedGoogle Scholar

Zsakeba HendersonM.D. 

Division of Reproductive Health, Centers for Disease Control and Prevention

4770 Buford Highway, NE, Mailstop K-23, Atlanta GA 30341-3724

Email: zhenderson@cdc.gov